Revisão integrativa da literatura sobre o potencial alvo farmacológico do fator de necrose tumoral alfa (TNF-α)
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora - Campus Avançado de Governador Valadares
DOI
Abstract
Tumor necrosis factor-alpha (TNF-α) is a relevant pharmacological target in the treatment of
inflammatory and autoimmune diseases. Understanding its role in the pathophysiology of
these conditions has driven the development of anti-TNF therapies, resulting in significant
advances in clinical management. Therefore, this study aims to evaluate the pharmacological
potential of TNF-α. This is an integrative literature review based on research from PubMed
and SciELO databases, considering publications between 2014 and 2024. The descriptors
used were "tumor necrosis factor TNF-α," "TNF-α agonist," "TNF-α antagonist," and
"rheumatoid arthritis TNF-α," in both Portuguese and English. 163 articles were identified, of
which 20 met the inclusion criteria: original articles, systematic reviews, and clinical trials
published in journals classified in strata A and B of the Capes Qualis system. Bibliometric
studies and partially published works were excluded.
The results showed that TNF-α plays a central role in mediating inflammation and is
associated with conditions such as ankylosing spondylitis, Crohn's disease, hidradenitis
suppurativa, juvenile idiopathic arthritis, plaque psoriasis, psoriatic arthritis, rheumatoid
arthritis, ulcerative colitis, and uveitis. The use of anti-TNF-α monoclonal antibodies, such as
infliximab and adalimumab, is highlighted in the treatment of these diseases. Despite their
effectiveness, these medications may cause adverse effects, requiring continuous monitoring
and therapeutic adjustments. Moreover, genetic variability influences the response to
anti-TNF therapies, impacting their efficacy and safety. Thus, personalizing treatment based
on genetic markers emerges as a promising strategy to optimize clinical outcomes. Future
research should explore new applications of anti-TNF-α agents and evaluate their long-term
effects.
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

